Partnership Opportunities

With the pace of novel immuno-oncology therapeutics, drug developers are seeking urgent help in more advanced, predictive tumour models for preclinical analysis to continue progressing pipelines and empowering clinical success.

While technology has matured, and our disease biology understanding has improved, there is still a huge gap between translational and clinical readouts.

Our Tumour Models community members are eager to partner with model developers & CROs, RNA-sequencers, imaging experts, 3D bioprinting enthusiasts, immunoassay specialists and bioinformatic software champions who can help them invigorate their drug discovery and development with confidence.

As the most well-established and longest-running community, the 11th Annual Tumour Models London will return this December.

After 2 years of virtual meeting, this is your opportunity to reconnect with your fellow colleagues face-to-face, expand your network with key preclinical and translational decision-makers across the UK and Europe.

As the only industry-led meeting focusing specifically on immuno-oncology tumour model utility, you can develop strategic relationshipsgain market insightnetwork with 100+ thought-leaders and showcase your expertise to affirm your position as a leader in preclinical oncology.

Can your platform or service help boost their clinical confidence to provide predictive data and ultimately help them get the best medicine to the patient? If so, we would love to hear from you!

Get in touch with Adam Mayer our partnerships director to find out more.

Why Partner?

pink

Engage, network, and foster your long-term relationships with Preclinical Immuno-Oncology Leaders from pharma majors and biotechs

orange

Showcase your pioneering solutions and expertise to differentiate yourself from other service providers in front of our expertly selected audience

purple

Assess the latest market intelligence to align your services with your customers' needs

orange

Gain invaluable insight to where the markets developing needs are, thereby allowing you to

Attendees by Seniority

seniority

Attendees by Company Type

company type